A Randomized Controlled Trial Evaluating the Effects of a Probiotic Containing Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 on Gastrointestinal Symptoms and Metabolomic Profiles in Female Dancers
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26125823 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Jakub Wiącek und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food and Nutrition, Poznan University of Physical Education, 61-871 Poznan, Poland. Hauptthemen laut MEDLINE: Probiotics, Lactobacillus helveticus, Bifidobacterium longum, Metabolome. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Poznan University of Physical Education, Doctoral School of J. Wiącek (Poznan University of Physical Education—Development of Young Researchers).
Abstract (Originalsprache)
Dancers experience physical and psychological stressors that can impact gut health. We hypothesized that a three-month supplementation with Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 would result in measurable alterations in the fecal metabolomic profile and improve gastrointestinal symptomatology in dancers. Of the 51 volunteers, 26 female dancers were randomized to a 12-week trial (NCT05567653). A homogenous group of 16 (probiotic: n = 5; placebo: n = 11) was analyzed. The participants received L. helveticus R0052 and B. longum R0175 (3 × 109 colony-forming units/day) or a placebo. Baseline dietary intake and body composition were recorded. Fecal samples were analyzed using liquid chromatography–mass spectrometry, and gastrointestinal symptoms were assessed with the Rome IV questionnaire. Statistical methods included principal component analysis, mixed-effects models, and analysis of variance–simultaneous component analysis (ASCA). The study revealed shifts in the probiotic group’s fecal metabolome (permutation test p = 0.026), including a reduction in (2RS)-2-(4-hydroxyphenyl)propionic acid (p = 0.023). No improvement in gastrointestinal symptoms was observed. No adverse events occurred. L. helveticus R0052 and B. longum R0175 may alter the gut metabolome, notably (2RS)-2-(4-hydroxyphenyl)propionic acid, but small sample size and absent symptom improvement limit the conclusions. Larger studies with varied doses and blood metabolite analysis are needed to confirm relevance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Food and Nutrition, Poznan University of Physical Education, 61-871 Poznan, Poland.
- Department of Biochemical Research, Pomeranian Medical University, 70-204 Szczecin, Poland.
- Sanprobi Sp. z o.o. Sp.K., 70-535 Szczecin, Poland.
ORCID-Profile: Jakub Wiącek, Karolina Skonieczna-Żydecka, Joanna Karolkiewicz
Förderung
- Poznan University of Physical Education
- Doctoral School of J. Wiącek (Poznan University of Physical Education—Development of Young Researchers)
Zitieren
APA
Wiącek, J., Skonieczna-Żydecka, K., Łoniewski, I., Styburski, D., Kaczmarczyk, M., & Karolkiewicz, J. (2025). A Randomized Controlled Trial Evaluating the Effects of a Probiotic Containing Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 on Gastrointestinal Symptoms and Metabolomic Profiles in Female Dancers. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26125823
Vancouver
Wiącek J, Skonieczna-Żydecka K, Łoniewski I, Styburski D, Kaczmarczyk M, Karolkiewicz J. A Randomized Controlled Trial Evaluating the Effects of a Probiotic Containing Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 on Gastrointestinal Symptoms and Metabolomic Profiles in Female Dancers. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26125823
BibTeX
@article{Wicek2025,
author = {Wiącek, Jakub and Skonieczna-Żydecka, Karolina and Łoniewski, Igor and Styburski, Daniel and Kaczmarczyk, Mariusz and Karolkiewicz, Joanna},
title = {A Randomized Controlled Trial Evaluating the Effects of a Probiotic Containing Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 on Gastrointestinal Symptoms and Metabolomic Profiles in Female Dancers},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26125823}
}
EUVIMED